COVID-19(14) effective(8) SARS-CoV-2(8) death(8) moderate(8) vaccine.(7) clinical trial(6) herpes zoster(6) Immunotherapy(6) Postherpetic neuralgia(6) monoclonal antibodies(6) HZ/su vaccine(6) Cytokine release syndrome(5) monoclonal antibody(5) pandemic(5) etesevimab(5) bamlanivimab(5) IL-6(5) mild to moderate(4) syndrome(4) objective(4) Patient(4) placebo group(4) reported(4) mAb(4) Effect(4) treated(4) Safe(4) tested(4) risk factor(4)